NCT07067177View on ClinicalTrials.gov

Prophylactic IV Paracetamol in Extremely Premature Infants

PHASE2/PHASE3Enrolling by invitationINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

October 1, 2025

Study Completion Date

October 20, 2025

Conditions
Patent Ductus Arteriosus in Preterm InfantsPatent Ductus Arteriosus After Premature BirthPatent Ductus Arteriosus (PDA)Patent Ductus Arteriosus in Premature Infants
Interventions
DRUG

Paracetamol (drug)

IV prophylactic paracetamol will be given prior to detection of PDA starting from 6 hours of age. It will be used to measure wethere this intervention reduces the risk of having persistant PDA, HsPDA, or any of their complications.

Trial Locations (3)

Unknown

Makassed, East Jerusalem

Al Ahli Hospital, Hebron

Palestine Medical Complex, Ramallah

All Listed Sponsors
lead

Al-Quds University

OTHER